FUSEN PHARM: VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING "COMPOUND POTASSIUM PHOSPHATE INJECTION" BEING ACCEPTED
Apr 23 06:58 ET
FUSEN PHARM: Next Day Disclosure Return
Apr 17 09:44 ET
FUSEN PHARM: Next Day Disclosure Return
Apr 16 09:42 ET
FUSEN PHARM: DISCLOSEABLE TRANSACTION SUBSCRIPTION OF INTEREST IN LIMITED LIABILITY PARTNERSHIP AND ENTERING INTO THE LIMITED PARTNERSHIP AGREEMENT
Apr 16 07:29 ET
FUSEN PHARM: VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING "METFORMIN EMPAGLIFLOZIN TABLETS (I)" ACCEPTED
Apr 3 10:09 ET
FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 2 09:39 ET
FUSEN PHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 28 10:32 ET
FUSEN PHARM: NOTICE OF BOARD MEETING
Mar 18 06:43 ET
FUSEN PHARM: PROFIT WARNING
Mar 15 08:24 ET
FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 1 08:35 ET
FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 1 08:31 ET
FUSEN PHARM: Next Day Disclosure Return
Jan 26 07:35 ET
FUSEN PHARM: Next Day Disclosure Return
Jan 25 07:32 ET
FUSEN PHARM: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 JANUARY 2024
Jan 22 06:00 ET
FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 7 19:09 ET
FUSEN PHARM: FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, 22 JANUARY 2024 (or at any adjournment thereof)
Jan 5 09:03 ET
FUSEN PHARM: NOTICE OF EXTRAORDINARY GENERAL MEETING
Jan 5 08:59 ET
FUSEN PHARM: (1) RENEWAL OF CONTINUING CONNECTED TRANSACTIONS AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING
Jan 5 08:55 ET
FUSEN PHARM: Arrangement of Electronic Dissemination of Corporate Communications for non-registered shareholders
Jan 3 09:50 ET
FUSEN PHARM: Arrangement of Electronic Dissemination of Corporate Communications for registered shareholders
Jan 3 09:48 ET
No Data
No Data